Podcasts about biomedical

Send us Fan MailAmelia Howe is a biomedical engineer and R&D project manager whose career spans startups, research labs, and established medical device companies. She currently leads cross-functional development programs at COLTENE, where she coordinates teams across engineering, quality, regulatory, and manufacturing to bring new medical devices from concept to international launch.Amelia's journey into engineering began with a pivotal shift early in her academic career. While studying at The University of Akron, she transitioned from nursing to biomedical engineering after discovering the field through biomechanics research. Working in Dr. Brian Davis's lab, she contributed to innovative research on shear forces and biomechanics, helping analyze how human movement affects pressure and stress on the body.After graduating summa cum laude, Amelia joined Neuronoff, Inc. as its first employee. In the fast-moving startup environment, she wore nearly every hat imaginable—conducting research, developing prototypes, establishing quality systems, and contributing to core patents. She played a key role in the early development of the Injectrode neuromodulation technology while helping build the company's quality management system toward ISO 13485 compliance.Over time, Amelia gravitated toward project leadership, recognizing that even highly talented engineers need structured coordination to ensure complex products make it through development. She moved into project management roles, overseeing multiple technical programs simultaneously and aligning engineering, regulatory, and business teams around clear timelines and milestones.Today, in addition to her role at COLTENE, Amelia is launching Chrysalis Business Consulting, where she provides project management and business development support to medical device startups. With both an engineering background and an MBA from Quantic School of Business and Technology, she brings a rare perspective that blends technical depth with strategic business insight. LINKS:Amelia Howe LinkedIn: https://www.linkedin.com/in/ameliaehowe/Company website: https://www.linkedin.com/company/chrysalis-business-consulting-llc/Aaron Moncur, host Subscribe to the show to get notified so you don't miss new episodes every Friday.The Being An Engineer podcast is brought to you by Pipeline Design & Engineering. Pipeline partners with medical & other device engineering teams who need turnkey equipment like cycle test machines, custom test fixtures, automation equipment, assembly jigs, inspection stations and more. You can find us at www.teampipeline.usWatch the show on YouTube: www.youtube.com/@TeamPipelineus 

In this episode of the MyHeart.net podcast, Dr. Alain Bouchard is joined by Dr. Norman Winn Seay to discuss chronic kidney disease, the connection between obesity and kidney health, and how early awareness, lifestyle changes, and newer medications can help protect kidney function.To learn more about kidney health and chronic kidney disease, explore our lastest article, Why Obesity Matters for Kidney Health.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

Aging has long been linked to a range of biological processes, including cellular senescence, epigenetic changes, and chronic tissue remodeling. Yet, these explanations often describe what happens during aging rather than why certain age-related diseases, such as fibrosis, continue to progress over time. In conditions like idiopathic pulmonary fibrosis (IPF), a key question remains: what drives the persistent activation of cells that should normally return to a resting state after injury? Increasing attention has turned to the interaction between cellular signaling pathways and epigenetic regulation as a potential explanation. Understanding how these processes work together to control gene expression and cell behavior is becoming an important focus in uncovering the mechanisms behind age-related disease. A new research paper was published in Volume 18 of Aging-US, titled “P38 MAPK is involved in epigenetic regulation of fibrotic genes in replication induced senescence in lung fibroblasts.” The study was led by first author Shan Zhu and corresponding author Yan Y. Sanders from the Department of Biomedical and Translational Sciences, Eastern Virginia Medical School (Macon & Joan Brock Virginia Health Sciences at Old Dominion University), in collaboration with Jennifer Q. Zhou, Kan Wang, and Ming-lei Guo from the same institution. Full blog - https://aging-us.org/2026/04/p38-mapk-driven-epigenetic-regulation-identified-as-a-key-mechanism-in-lung-fibrosis/ Paper DOI - https://doi.org/10.18632/aging.206357 Corresponding author - Yan Y Sanders - sandery@odu.edu Abstract video - https://www.youtube.com/watch?v=yP0CwWMUhnY Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206357 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, senescence, fibroblast activation, p38 MAPK, lung fibrosis, H4K16Ac To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

In this episode of Data in Biotech, host Ross Katz sits down with Kevin Brown, co-founder of Standard BioModel, to explore one of the most ambitious projects in biomedical AI, building a multimodal foundation model that represents the full complexity of a patient across time.  Drawing on a career spanning brain-computer interfaces, computer-aided diagnosis at Siemens Healthineers, and oncology data science at Bristol Myers Squibb, Kevin shares the scientific and philosophical journey that led him to a single conviction: a patient is not a document. Rather than reducing a patient to clinical notes, ICD-10 codes, or isolated test results, Standard BioModel's approach maps every available modality - CT imaging, digital pathology, genomics, EKGs, longitudinal EHR data - into a shared latent space, and models how that patient moves through time.  The result is a framework designed not just for prediction, but for counterfactual reasoning, clinical trial matching, and personalized intervention, with open-source models already being validated across leading academic medical centers. What you'll learn in this episode:  >> Why reducing a patient to text - clinical notes, radiology reports, genomic assay summaries - and how mapping multimodal data into a shared latent embedding space preserves information that never makes it into the written record >> How Standard BioModel's temporal architecture models patients as trajectories through an abstract embedding space rather than static snapshots, enabling counterfactual reasoning about the likely impact of interventions on a patient's future health trajectory >> Why no single foundation model can own every clinical vertical and how building a highly generalizable base model that facilitates downstream fine-tuning is a more defensible and scalable strategy than building narrow, application-specific models >> How the model handles missing modalities in real-world clinical settings, and why the architecture is designed to function effectively even when not every data type is available for every patient >> Why Standard BioModel has chosen to open-source its models and why broad, institution-specific validation across diverse patient populations is not just a scientific priority, but a prerequisite for trustworthy clinical AI Meet our guest: Kevin Brown is the Founder and CEO of Standard Model Biomedicine, where he builds foundation models for biomedicine. He previously led AI work as Director of Artificial Intelligence at SimBioSys, and held data science and applied ML roles at Bristol Myers Squibb and Siemens Healthineers. With a neuroscience research background from New York University, Kevin's work spans generative AI and machine learning for biomedical and medical imaging applications. Connect with Kevin Brown on LinkedIn  About the host: Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation. Connect with Ross Katz on LinkedIn Connect with us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode! Sponsored by… This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.

Explore the BITSDIS 2 opportunity from the Department of the Interior, a $250M IDIQ focused on biomedical IT, software development, and informatics support. This episode breaks down the scope, competition landscape, and what vendors need to position themselves effectively for this high-value, full-and-open contract.Listen now to stay ahead in federal contracting tune in now and start preparing your strategy before the April 30 deadline.Contact ProposalHelper at sales@proposalhelper.com to find similar opportunities and help you build a realistic and winning pipeline. 

In this episode of the MyHeart.net podcast, Dr. Alain Bouchard is joined by Dr. Chris DeGroat, a cardiologist at Cardiology Specialists of Birmingham, to discuss all things peripheral artery disease.To learn more about new methods for combating peripheral artery disease, explore our article, The Next Frontier in Peripheral Artery Disease Treatment.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

This episode of the Physics World Weekly podcast features Brian Pogue, who is professor of biomedical engineering at Dartmouth College in the US. He is also the co-founder of several start-up companies that are developing optics-based systems for medicine. In conversation with Physics World's Tami Freeman, Pogue explains that optical technologies underlie many of today's routine medical procedures. The field of optics is also converging with the world of medical physics, and Pogue talks about exciting new techniques for guidance, dosimetry and in vivo verification of radiation therapy cancer treatments. This interview was recorded in association with the journal Physics in Medicine & Biology, which celebrates its 70th anniversary this year. This podcast is supported by One Physics, your trusted, local partner in medical physics and radiation safety.

Send us Fan MailDr. Melisa Buie is a problem solver, author, and operational excellence leader known for making complex systems work better. Her work spans advanced technologies such as lasers and semiconductor equipment, as well as large-scale global manufacturing and business systems.Melisa's career sits at the intersection of engineering innovation and operational performance. She has held key roles with leading organizations in the semiconductor and photonics industries, including Lam Research, Coherent, Applied Materials, and Advanced Energy. As Global Director for Lean Operational Excellence at Coherent, Inc., a $2B global photonics solutions company, she led initiatives that advanced both engineering performance and enterprise-wide transformation. Earlier in her career, she served as a Member of the Technical Staff and Engineering Manager at Applied Materials and Advanced Energy, and as a Research Scientist with Science Applications International Corporation at the Naval Research Laboratory in Washington, D.C., where she focused on theoretical laser systems.In addition to her industry leadership, Melisa is an author and educator. She wrote Problem Solving for New Engineers: What Every Engineering Manager Wants You to Know in 2017, drawing on her experience bridging industry and academia. She also taught graduate-level courses for nearly a decade at San Jose State University in the Department of Biomedical, Chemical, and Materials Engineering, where she helped develop the next generation of engineering leaders and problem solvers.A Few Quotes From This Episode“If it's safe to fail, then it's safe to learn and grow.” “Experimentation is something that leads to a lot of failure.” “Part of the reason we don't like failing is because of all the emotions that come with it.” “You've got to separate the story you make up about the failure.” Resources Mentioned in This Episode Book: Faceplant: Free Yourself From Failure's Funk by Buie and colleaguesBook: Problem Solving for New Engineers: What Every Engineering Manager Wants You to Know by BuieAbout The International Leadership Association (ILA)The ILA was created in 1999 to bring together professionals interested in studying, practicing, and teaching leadership. About  Scott J. AllenWebsiteWeekly Newsletter: Practical Wisdom for LeadersMy Approach to HostingThe views of my guests do not constitute "truth." Nor do they reflect my personal views in some instances. However, they are views to consider, and I hope they help you clarify your perspective. Nothing can ♻️ Please share with others and follow/subscribe to the podcast!⭐️ Please leave a review on Apple, Spotify, or your platform of choice.➡️ Follow me on LinkedIn for more on leadership, communication, and tech.

I dag dykker vi ned i øjets anatomi og hvordan synet egentlig virker. 1: Hvordan synet virker2: Hvad er langsynet / kortsynet3: Grå stær4: Laser Eye Surgery5: Nat linser6: Elektrisk omformning af øjet 7: Guld i Øjet8: Chip i øjet----------1: Hvordan synet virkerHjerne / Synet forbindelsehttps://videnskab.dk/krop-sundhed/oejet-kigger-men-hjernen-ser/2: Hvad er langsynet / kortsynetØjets form3: Grå stærHvad er det?4: Laser Eye SurgeryLASIKFor those who want do do away with corrective lenses, the main option is LASIK (Laser-Assisted In Situ Keratomileusis) surgery, which uses a laser to reshape the cornea by removing microscopic amounts of tissue beneath a thin flap, allowing light to focus properly on the retina. While, for those suitable for treatment, LASIK has a high success rate – around 95% of patients go on to ditch their glasses only a few days after recovering from surgery – it's expensive and invasive, and cutting into the cornea alters the structural integrity of the eye.“LASIK is just a fancy way of doing traditional surgery,” said lead researcher and presenter Michael Hill, a professor in chemistry at Occidental College. “It's still carving tissue – it's just carving with a laser.”5: Nat linserhttps://www.city-optik-muenchen.de/en/orthokeratologie-muenchen-ortho-k-nachtlinsen/Orthokeratology, or Ortho-K, offers a revolutionary way to correct vision without the need for glasses or daytime contacts. By wearing special contact lenses overnight, users can reshape the cornea and experience clear vision throughout the day. This method challenges the conventional approach to eyesight correction, offering a non-invasive alternative for those seeking freedom from corrective lenses.The cornea is the transparent part of the eye on which the contact lens is placed. It consists of five layers of different thicknesses. However, only the uppermost layer, the so-called epithelium, is important for us.Corneal epitheliumBowman membranestromaDescement's membraneendotheliumThe corneal epithelium is about 0.04mm to 0.06mm thick. It is the uppermost layer of the cornea and renews itself completely once in 7 days. Such an epithelium as it occurs on the eye, there is similarly also on the “normal” skin on the human body. Such an epithelium scales itself off and is thus a protection for the underlying tissue. The Ortho-K contact lens makes use of this process by pushing the top layer of the epithelium from the middle of the cornea (directly above the pupil) to the edge by adhesive forces (tensile forces). Since only the top layer of the epithelium is moved here, the natural protective mechanism of the eye is fully preserved. In addition, this effect of orthokeratology is reversible due to the rapid regeneration time of the epithelium. This means that if the contact lens is no longer worn, it will take another 7 days for the old shortsightedness to be restored. Orthokeratology is in no way harmful to the eye compared to laser eye surgery, which destroys tissue in much deeper layers (stroma) in order to achieve a lasting effect. Recent studies from the USA, on the other hand, have even pointed out that the eye dioptres in orthokeratological contact lenses remain very constant, i.e. do not change. For this reason, Ortho-K contact lenses are also used with children who are already very shortsighted at a young age. In general, there is no age limit for orthokeratology.6: Elektrisk omformning af øjethttps://bli.uci.edu/laser-free-vision-correction-uses-electrical-current-to-reshape-eye/Electric Eye Treatment (EMR - electromechanical reshaping)Denne teknik er stadigvæk ikke godkendt til mennesker, men de er i gang med kliniske forsøg.Scientists have developed a novel, non-invasive technique that reshapes the cornea using only a mild electric current and a temporary pH shift. The cornea is the clear, dome-shaped surface at the front of the eye, acting as a transparent window that helps focus incoming light. It's made of tightly packed collagen fibers and is designed to be strong and smooth. When light enters the eye, the cornea is the first lens it hits – and it's here that most of light-bending (refraction) occurs in order to focus the light onto the retina at the rear of the eye. However, if the cornea has an irregular curve, it results in conditions such as nearsightedness (myopia) and farsightedness (hyperopia).What Hill and colleagues propose is instead working with the composition of the cornea to reshape the dome without removing any material from it. Made primarily of collagen, the cornea maintains its shape thanks to the arrangement of charged molecules and proteins. The researchers discovered that by applying a low-level electrical current through a specially designed platinum “contact lens” electrode, they could change the pH of the tissue, increasing the acidity of the corneal tissue, which would make it pliable just long enough to reshape – like fitting something into a mold. In this case, the mold is the platinum lens.Then, once the current stops and the pH returns to normal, the cornea hardens again and holds its mold-fitted shape. The whole process takes about a minute, requires no cutting or removal of tissue, and, so far, has shown no structural damage or cell death in the tested samples. 7: Guld i Øjethttps://www.sciencealert.com/gold-injections-in-the-eye-may-be-the-future-of-vision-preservationThe macula is responsible for the central, high-resolution, color vision that is possible in good light. This kind of vision is impaired if the macula is damaged, as in macular degeneration (AMD). AMD: Sygdommen ødelægger de celler i nethinden, der opfanger lys, og gør det svært at se skarpt. 20-30 procent af befolkningen over 70 år får denne sygdom.Biomedical engineer Jiarui Nie, from Brown University in Rhode Island:This is a new type of retinal prosthesis that has the potential to restore vision lost to retinal degeneration without requiring any kind of complicated surgery or genetic modification. We believe this technique could potentially transform treatment paradigms for retinal degenerative conditions.How: very fine gold nanoparticles, thousands of times thinner than a human hair, are laced with antibodies to target specific eye cells. They're then injected into the gel-filled vitreous chamber between the retina and the lens. Next, a small infrared laser device is used to excite these nanoparticles and activate specific cells in the same way photoreceptors do. If the treatment makes it to us humans as well, that laser could be embedded in a pair of glasses.So far it looks like the nanoparticles could help bypass damaged photoreceptors (in Mice).Dette er endnu ikke blevet testet på mennesker8: En microchip i Øjethttps://videnskab.dk/krop-sundhed/lille-traadloes-chip-i-oejet-kan-potentielt-genskabe-synet-hos-aeldre-med-oejensygdom/En anden behandling af AMD.En trådløs chip kan måske give ældre mennesker med fremskreden øjensygdom noget af synet tilbage.Opfindelsen bygger på en ny teknologi kaldet PRIMA-systemet, der består af to dele: Første del er en fleksibel, trådløs chip på 2×2 millimeter, som erstatter de ødelagte sanseceller. Den anden del er et par specielle briller, der opfanger billeder og sender dem som usynligt infrarødt lys til chippen, der omdanner signalerne til elektriske impulser, som sendes videre til hjernen.Forskerne forventer ikke at kunne genskabe helt normalt syn med chippen alene, men de arbejder videre på at forbedre livskvaliteten for patienterne. »Jeg tror ikke, vi nogensinde vil kunne genskabe fuldt 20/20-syn (normal synsstyrke, red.) med implantatet alene [...], men et af de største ønsker, vi hører fra patienter, er at kunne genkende ansigter og følelser igen - og det arbejder vi hen mod,« siger han i pressemeddelesen. Indtil videre er chippen kun godkendt til forskningsbrug, men firmaet Science Corporation har ansøgt om godkendelse til klinisk brug i Europa.Der er allerede forsøg med mennesker. 38 deltagere over 60 år på 17 klinikker i fem europæiske lande. Efter et års brug af systemet havde 26 ud af 32 deltagere, der gennemførte hele forløbet, opnået tydelige forbedringer i synet.

Join LaTangela as she chats with Dr. Newton and Dr. Carmichael on the #TanLine Pennington Biomedical Research Center has been a staple in our community for years. Providing information and resources to strengthen our communities one block at a time. Mark your calendars for the Senior Black American Health Fair Saturday, April 11, 2026 8:30 - 1p.m. Pennington Biomedical - Conference Center Health Screenings, Bingo, Line Dancing, Fitness Stations and MORE! FREE and open to the public. FREE valet parking will also be available. For more information: www.PBRC.edu/SBAHF RADIO - WEMX- Baton Rouge, La. Mon-Fri 10a.m.-3p.m.CST KTCX - Beaumont, Tx. Mon-Fri 3-8 CST KMEZ - New Orleans, La. Mon-Fri 7-12mid WEMX Sundays 6a.m. KSMB Sundays 6a.m. WWO - YouTube - #LaTangelaFay Podcast - ALL digital platforms - #iTunes #Spotify #WEMX www.LaTangela.com www.TanTune.com Special Thank You - Gordon McKernan Injury Attorney - Official Partner #GordonGives #TanCares #225BulletinBoard TanTune #POOF Power Over Obstacles Forever GT Legacy AutoThe Fiery CrabHair Queen Beauty Super CenterSee omnystudio.com/listener for privacy information.

In this episode of the Not Your Average Autism Mom podcast, Shannon Urquiola explores a topic many parents quietly wonder about but don't always know how to navigate: biomedical testing and autism.Shannon discusses common tests that are often mentioned in the autism community—including OATS testing, MTHFR genetic variants, CBC panels, vitamin deficiencies, gut health testing, and sleep studies—and why some parents begin asking whether certain behaviors could have underlying biological contributors.This conversation is not about curing autism.It's about understanding that sometimes discomfort, inflammation, nutritional deficiencies, or sleep disruptions can affect a child's regulation—and those things deserve attention.Throughout the episode Shannon emphasizes three key principles:• Autism is not something to cure• Curiosity should guide decisions—not panic• Discernment matters in a very noisy spaceYou'll also hear real-life scenarios that many parents will recognize, along with the important reminder that biomedical testing isn't the right path for every family—and that's okay too.Shannon also invites listeners to share their own experiences with biomedical testing so the community can learn from one another.If you've ever wondered whether certain behaviors might have medical contributors, this episode will help you think through the conversation in a thoughtful and grounded way.Shannon is also hosting a FREE 3-part educational series on stem cells and autism beginning March 17th.If you're curious about emerging research in this area, you can register HERE or find the information across Not Your Average Autism Mom social media.We have so many of you who are NEW here, we wanted to share Shannon's feature on News Nation Now with Nichole Berlie. She shares her perspective as a mom raising an autistic son and as the founder of Not Your Average Autism Mom.Every chance she gets to use her voice for families like ours is a privilege—and this conversation was no exception.

Maybe you've heard of CAR-T cells, a type of cell you have in your body that is supercharged in a lab and put back in to fight things like cancer. Biomedical engineering expert Jeremy Green at Johns Hopkins and colleagues … There's a new technique that may revolutionize one type of T cell therapy, Elizabeth Tracey reports Read More »

CAR-T cells are a type of immune cell that have proven very effective for treating some types of cancer, yet limitations to their use exist. Biomedical engineering expert Jordan Green at Johns Hopkins says limitations including lengthy time and expense … Can an injectable particle help supercharge your T cells? Elizabeth Tracey reports Read More »

The Most Powerful Drug Ever? The GLP-3 Revolution ExplainedWhat if the most powerful drug ever created is already here, and we're not fully prepared to use it correctly?In this episode of the Smart Nutrition Made Simple Show, Ben Brown sits down with Jay Campbell, five-time international best-selling author and leading expert in hormonal optimization, performance enhancement, and longevity science, to unpack the GLP-3 revolution.Jay explains why Retatrutide, the newest GLP drug in development, is already being forecasted as “the greatest drug of all time” — and how it may fundamentally redefine fat loss, metabolic health, and longevity.But this conversation goes deeper than hype.We explore the biomedical revolution unfolding right now, how GLP-1, GLP-2, and GLP-3 drugs actually work, why most people are using them incorrectly, and the difference between strategic microdosing and reckless overdosing.Jay breaks down:• Why Retatrutide could potentially end obesity• Why dosing strategy changes everything• How GLP drugs influence appetite, inflammation, brain signaling, and metabolic pathways• Why foundation matters more than pharmaceuticals• The psychological and physiological implications of long-term use• What the next decade of metabolic medicine may look likeThis is not a surface-level fat loss discussion. It's a conversation about discernment, responsibility, and how to use powerful tools without becoming dependent on them.If GLP-3 truly represents a biomedical revolution, the real question becomes: Are we ready for it?Tune in now to understand the science behind GLP-3, Retatrutide, metabolic optimization, and the future of human performance.Timestamps00:00 – Retatrutide Is GLP-301:12 – “The Greatest Drug of All Time?”03:40 – GLP-1 vs GLP-2 vs GLP-3 Explained07:15 – Appetite Suppression vs Metabolic Rewiring12:20 – The Dosing Problem in Clinical Medicine18:30 – Microdosing vs High Clinical Doses22:45 – Can Retatrutide End Obesity?26:00 – Why Foundation Still Wins: Sleep, Protein, Resistance Training30:10 – Brain Chemistry, Addiction, and GLP Effects34:20 – Biomarkers, Inflammation & Metabolic Health39:50 – Rebound Weight Gain and Microdose Strategy44:30 – The Biomedical Revolution47:10 – Overreach vs Optimization52:00 – Where to Connect with JayConnect with Jay CampbellWebsite: https://jaycampbell.comInstagram: https://www.instagram.com/jaycampbell333Links & ResourcesConnect with Ben on Instagram: https://www.instagram.com/bodysystemscoaching/Learn more about Ben's coaching program: www.bodysystems.comSubscribe to the Smart Nutrition Made Simple Show on Apple Podcasts - https://podcasts.apple.com/us/podcast/the-smart-nutrition-made-simple-show-with-ben-brown/id1244912234Spotify - https://open.spotify.com/show/4H8vUlwYvKcAXZOv84sFgTYoutube - https://www.youtube.com/@bodysystemscoachingBook Free Nutrition Strategy Call - https://bodysystems.com/free-strategy-call/

BUFFALO, NY — March 10, 2026 — A new #research paper was #published in Volume 18 of Aging-US on March 3, 2026, titled “P38 MAPK is involved in epigenetic regulation of fibrotic genes in replication induced senescence in lung fibroblasts.” Led by Shan Zhu — with corresponding author Yan Y Sanders from the Department of Biomedical and Translational Sciences, Eastern Virginia Medical School (Macon & Joan Brock Virginia Health Sciences at Old Dominion University) — the study examines how the stress-activated kinase p38 MAPK contributes to persistent profibrotic gene expression in replicative (passage-driven) senescence of human lung fibroblasts and in primary fibroblasts from patients with idiopathic pulmonary fibrosis (IPF). Using IMR90 lung fibroblasts at low and high population-doubling levels and primary IPF fibroblasts, the authors show that TGF-β1 upregulates profibrotic genes (α-SMA and Col3A1) in both young and near-senescent cells, but that high-PDL (near-senescent/senescent) fibroblasts exhibit a delayed but sustained p38 MAPK response to TGF-β1. Pharmacological inhibition of p38 MAPK (SB202190) blunted profibrotic transcription and reduced H4K16 acetylation (H4K16ac) enrichment at α-SMA and Col3A1 promoters, indicating an epigenetic mechanism linking p38 signaling to fibrotic gene activation. “These findings suggest that a p38 MAPK–dependent epigenetic mechanism is involved in fibroblast activation, supporting the therapeutic potential of p38 MAPK inhibition for treating age-related fibrotic diseases such as IPF.” The authors place these molecular results in a clinical context: persistent fibroblast activation and senescence are features of IPF and other age-associated fibrotic disorders, and the data here support targeting p38 MAPK to interrupt an epigenetically reinforced profibrotic program. The study used multiple readouts (western blot, RT-qPCR, ChIP for H4K16ac) and included primary IPF cells to strengthen translational relevance, while also noting that further work is required to test safety and efficacy in vivo. The paper outlines clear next steps: determine the upstream triggers that sustain p38 signaling in near-senescent fibroblasts, map the chromatin-level events downstream of p38 that maintain H4K16ac at profibrotic promoters, and evaluate p38 inhibition in animal models of age-related pulmonary fibrosis. The authors also recommend exploring whether epigenetic modulators that reverse H4K16ac enrichment can synergize with kinase inhibition to restore repair capacity without impairing normal tissue healing. DOI - https://doi.org/10.18632/aging.206357 Corresponding author - Yan Y Sanders - sandery@odu.edu Abstract video - https://www.youtube.com/watch?v=yP0CwWMUhnY Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206357 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, senescence, fibroblast activation, p38 MAPK, lung fibrosis, H4K16Ac To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

Andria Parks, Head of Commercial Operations at First Ascent Biomedical, highlights the value of using a biopsy to grow cancer cells in a lab to determine which drugs are most likely to be effective against a specific cancer. This functional medicine approach combines lab data, genomic data, and AI to produce a report that identifies which drugs might work and which are unlikely to be effective for that individual patient. This perspective is particularly effective for rare cancers, which often lack established treatment guidelines.  Andria explains, "First Ascent Biomedical is a functional precision medicine company. And what that means is we've put together three very unique and advanced technologies to produce something very specific, and I'll explain what that means. What we do is we take a fresh biopsy from a patient, and we will grow those cells in our lab in a medium very similar to the human body. We will test or validate more than 150 drugs and drug combinations on those cells to see what works on those cells and what kills them. We will combine that with a patient's genomic information using our advanced AI. And then a report is produced that stack ranks the drugs that work, but most importantly, the drugs that don't work for that patient's cancer. And when a physician sees that report, they know exactly what to start with before initiating treatment. So everything we do is outside the body."   "If you are testing 150 drugs and combinations on your unique cancer cells, you will be able to know what works and doesn't ahead of time. Usually, most patients who don't follow this approach go through a standard-of-care protocol. And what that means is these protocols or ways of treating patients are based on hundreds of thousands of patients that may look like you and me, but are not you and me. So it's based on evidence of many, many, many patients with a similar type of profile. But the uniqueness of getting a drug to work for your specific cancers is based on your unique cells. So that's what makes a big difference. You may see 20% - 40% that works, but without knowing if they were tested on your cancer cells, and that's what makes a big difference with what functional precision medicine in oncology delivers." #FirstAscentBiomedical #PrecisionMedicine #CancerResearch #Oncology #PersonalizedMedicine #HealthTech #RareCancer #Innovation #FunctionalMedicine #AI #Biotech #PatientCare firstascentbiomedical.com Download the transcript here

Andria Parks, Head of Commercial Operations at First Ascent Biomedical, highlights the value of using a biopsy to grow cancer cells in a lab to determine which drugs are most likely to be effective against a specific cancer. This functional medicine approach combines lab data, genomic data, and AI to produce a report that identifies which drugs might work and which are unlikely to be effective for that individual patient. This perspective is particularly effective for rare cancers, which often lack established treatment guidelines.  Andria explains, "First Ascent Biomedical is a functional precision medicine company. And what that means is we've put together three very unique and advanced technologies to produce something very specific, and I'll explain what that means. What we do is we take a fresh biopsy from a patient, and we will grow those cells in our lab in a medium very similar to the human body. We will test or validate more than 150 drugs and drug combinations on those cells to see what works on those cells and what kills them. We will combine that with a patient's genomic information using our advanced AI. And then a report is produced that stack ranks the drugs that work, but most importantly, the drugs that don't work for that patient's cancer. And when a physician sees that report, they know exactly what to start with before initiating treatment. So everything we do is outside the body."   "If you are testing 150 drugs and combinations on your unique cancer cells, you will be able to know what works and doesn't ahead of time. Usually, most patients who don't follow this approach go through a standard-of-care protocol. And what that means is these protocols or ways of treating patients are based on hundreds of thousands of patients that may look like you and me, but are not you and me. So it's based on evidence of many, many, many patients with a similar type of profile. But the uniqueness of getting a drug to work for your specific cancers is based on your unique cells. So that's what makes a big difference. You may see 20% - 40% that works, but without knowing if they were tested on your cancer cells, and that's what makes a big difference with what functional precision medicine in oncology delivers." #FirstAscentBiomedical #PrecisionMedicine #CancerResearch #Oncology #PersonalizedMedicine #HealthTech #RareCancer #Innovation #FunctionalMedicine #AI #Biotech #PatientCare firstascentbiomedical.com  Listen to the podcast here

Is fatty liver disease reversible through diet?Amy Goss, PhD, Associate Professor of Nutrition Sciences at UAB and Registered Dietitian, returns to the MyHeart.net podcast to discuss metabolic-associated steatotic liver disease (MASLD), also known as fatty liver disease, and her research on how a carbohydrate-restricted diet may help reduce liver fat in those already diagnosed with the condition. Learn practical tips on making dietary changes that are both effective and sustainable.To read more about how exercise, diet, and other lifestyle changes may help with MASLD by exploring our article, Lifestyle Intervention as the Foundation of Care in Obesity-Related Fatty Liver Disease (MASLD).About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

This episode is a masterclass in both men and women's hormonal health. These hormones in effect are the clocks of aging, so much so that biotech labs can now take a few data points, consult with AI and provide you with an almost exact time until major hormonal events like menopause. Which is crucially important because to optimize health and longevity the right type of hormonal support and treatment should be started years before that. This episode is for anyone wanting to understand how hormones are the backbone of overall health, aging slower, maintaining sexual function and looking younger for longer.Dr. Amy Killen, MD received her Bachelor's degree in Biomedical science from Texas A&M University and then her MD from UT Southwestern Medical School. She completed an Emergency Medicine residency at the University of Arizona. She worked for many years in Austin, Texas as a board-certified emergency physician before moving to Portland and becoming the medical director of an anti-aging specialty clinic. Now in Utah, Dr. Killen embraces bio-identical hormone therapy and personalized medicine and offers aesthetics services, including Botox, Fillers, and Microneedling. Dr. Killen is also enthusiastic about cutting-edge rejuvenating medicine techniques, using Platelet Rich Plasma Natural Growth Factor Injections for skin rejuvenation, hair restoration, urinary incontinence, and sexual dysfunction.Contact:Website - https://dramykillen.comInstagram - @dr.amybkillen Join us as we explore:Hormone optimization, TRT and infertility, estrogen dominance in BOTH men and women and hormone enhancing (or not) peptides.Estrogen vs estrone vs estriol vs estradiol.Sexual health, ovarian aging, HRT, perimenopause and the ability of AI to predict your age of menopause onset.Why men would supplement with progesterone.  Why everyone should get a DEXA scan.Sleep optimization, skin optimization, birth control, Bryan Johnson and other biohacking insights.MentionBiotech - TimeLessBiotech, https://timelessbiotech.comBiotech - LifeAhead, https://lifeahead.coSupport the showFollow Steve's socials: Instagram | LinkedIn | YouTube | Facebook | Twitter | TikTokSupport the show on Patreon:As much as we love doing it, there are costs involved and any contribution will allow us to keep going and keep finding the best guests in the world to share their health expertise with you. I'd be grateful and feel so blessed by your support: https://www.patreon.com/MadeToThriveShowSend me a WhatsApp to +27 64 871 0308. Disclaimer: Please see the link for our disclaimer policy for all of our content: https://madetothrive.co.za/terms-and-conditions-and-privacy-policy/

This edWeb podcast is sponsored by Project Lead The Way.The edLeader Panel recording can be accessed here.When students think about medical careers, “nurse” or “doctor” is often at the top of the list. But today's biomedical landscape is far more expansive, spanning fields like biomedical engineering, laboratory sciences, data and health informatics, research, and technology innovation.This edWeb podcast explores how K–12 schools can spark student interest in the full spectrum of biomedical careers through interdisciplinary learning, authentic experiences, and strategic pathway design. We dive into practical strategies for:Expanding student awareness of biomedical careers beyond traditional clinical rolesIntegrating biomedical science with computer science and engineering and other Career and Technical Education (CTE) pathways to reflect real-world innovationLeveraging professional industry certification and licenses as well as other assets to connect learning to meaningful opportunitiesBuilding pathways that start before high school, sustaining student engagement across grade levelsHighlighting college credit and postsecondary opportunities that give students a strong head startBy the end of this session, listeners are able to:Identify a range of biomedical career pathways beyond nursing and clinical roles that are relevant to K–12 students and design and adapt strategies to engage students in these pathwaysExplain how integrating biomedical science with computer science and engineering strengthens student learning and career readinessBuild and strengthen postsecondary and workforce opportunities to enhance K–12 learning pathways, and identify how industry-recognized credentials and college credit options can enhance pathwaysThis edWeb podcast is of interest to K–12 teachers, CTE coordinators, school leaders, and district leaders.Project Lead The WayEmpower Students to Thrive in an Evolving WorldDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Learn more about viewing live edWeb presentations and on-demand recordings, earning CE certificates, and using accessibility features.

In this episode of the MyHeart.net podcast, Dr. Alain Bouchard discusses the interplay between Heart Failure with Preserved Ejection Fraction, or HFpEF, and obesity with Dr. Michelle Kittleson, Director of Heart Failure Research at the Smidt Heart Institute at Cedars-Sinai.Learn more about the diagnosis, challenges, and management of this condition by exploring our article, Managing Obesity in Heart Failure with Preserved Ejection Fraction (HFpEF).About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

Takeaways* Misalignment in job roles can lead to dissatisfaction.* Finding purpose is crucial for motivation and alignment.* Imposter syndrome affects many high achievers.* Feedback from others can reveal blind spots.* Surrounding yourself with supportive people is essential.* Energy management is key to avoiding burnout.* Career success requires intentionality and planning.* The coaching process involves visioning and self-assessment.Chapters03:14 The Importance of Alignment in Career Choices06:21 Understanding Purpose and Its Role in Career Satisfaction09:02 The Framework of Intentional Change12:05 Closing the Gap: Ideal Self vs. Real Self15:02 Overcoming Mindsets: Victim Mentality and Imposter Syndrome18:15 The Power of Feedback and Self-Reflection21:03 Running Towards Goals vs. Running Away from Fear27:17 Exploring Alignment in Life and Career29:57 The Importance of Values in Decision Making33:06 Energy Management and Avoiding Burnout37:46 Insights from Biomedical Engineering42:28 Coaching Approach: From Seed to BloomKaren Ayoub is a career coach who helps early career professionals overcome self doubt and impostor syndrome so they can achieve their next promotion or job move. Her 5-step program provides strategies and support for clients at every stage, with both mindset transformation and tactical approaches to achieve this outcome. She holds a professional coaching certificate and MBA from Case Western. Karen also works as a Senior Project Manager in the medical device industry. Outside of work, Karen enjoys traveling, reading, cooking, and going to museums. Connect With Karen:LinkedIn Profile: https://www.linkedin.com/in/karenayoub/Cody's content: https://linktr.ee/cjones803#podcast #purewisdompodcast #personalgrowth #motivation #mindset #facingfears #selfidentity #inspiration #selfimprovement #psychology #entrepreneurship #fitness #fitnessmotivation #business #career #dating #relationships #lifecoach #healthandwellness #workout #coaching #careercoaching #alignment #impostersyndrome #personalgrowth #feedback #energymanagement #biomedicalengineering #motivation #self-doubt #professionaldevelopmentDisclaimer: Any information discussed in this podcast is for entertainment purposes only and is not intended to act as a substitute for professional, medical, legal, educational, or financial advice. The following views and opinions are those of the individual and are not representative views or opinions of their company or organization. The views and opinions shared are intended only to inform, and discretion and professional assistance should be utilized when attempting any of the ideas discussed. Pure Wisdom Podcast, LLC, its host, its guest, or any company participating in advertising through this podcast is not responsible for comments generated by viewers which may be offensive or otherwise distasteful. Any content or conversation in this podcast is completely original and not inspired by any other platform or content creator. Any resemblance to another platform or content creator is purely coincidental and unintentional. No content or topics discussed in this podcast are intended to be offensive or hurtful. Pure Wisdom Podcast, LLC, its host, its guest, or any company participating in advertising through this podcast is not responsible for any misuse of this content.

According to the Oxford English Dictionary, the word 'recent' is defined as “having happened or started only a short time ago.” And yet, in the world of scientific publishing, it may be one of the most imprecise terms ever used. Jeff and Anthony take a look at a 'recent' study that aims to quantify exactly what is meant by the term. How is Billy Joel involved? You'll have to listen to find out.Support the show and get bonus episodes, videos, Discord community access and more! http://patreon.com/wehaveconcernsJeff on Blue Sky: https://bsky.app/profile/jeffcannata.bsky.socialAnthony on Blue Sky: https://bsky.app/profile/acarboni.bsky.socialLink to today's story: https://www.bmj.com/content/391/bmj-2025-086941

In this episode, Dr. Jun Ding joins us to explore how artificial intelligence and machine learning are reshaping biomedical research at the cellular level. Dr. Ding is an Assistant Professor in the Division of Respiratory Medicine at the Research Institute of the McGill University Health Centre and leads the Ding Lab at McGill University's Meakins-Christie Laboratories. Dr. Ding's research focuses on decoding cell dynamics across complex diseases by leveraging advanced single-cell technologies and computational biology. By developing machine-learning models such as probabilistic graphical models, Dr. Ding and his team aim to bridge massive omics datasets with actionable biological insight – paving the way for next-generation diagnostics and therapeutics… Hit play to discover: Why understanding cell dynamics is critical to tackling complex diseases like cancer. How single-cell and spatial omics technologies are revealing previously hidden biological heterogeneity. The role of machine learning in modeling disease progression and identifying new drug targets. To learn more about Dr. Ding and his work, visit The Ding Lab website!

Jim Foote, Co-Founder and CEO of First Ascent Biomedical, is changing the standard of care for cancer treatment from 'try and hope' to 'test and treat'. The First Ascent platform combines functional drug testing of fresh biopsies, genomic sequencing, and an AI engine to assess a large panel of drugs and identify the most likely to be effective. Clinical data show a high correlation between how cancer cells respond in the lab test and how patients respond to the same drug, and is seen as a treatment guide for refractory cancer patients to identify novel drug combinations. Jim explains, "Fundamentally speaking, if we look at everybody on this planet from a DNA and RNA perspective, there are 8 billion people, and each one of us is different from the others due to our DNA and RNA. So if we acknowledge that biologically we're all different, then the problem that we're trying to solve is if we're all different, why are we treating each patient with the same standard of care? A process that has existed for a hundred years, and again, they've made substantial advancements, but functional precision medicine is really an opportunity to move away from a standard that's based on the laws of averages and really treat people based on an individual level, developed by results that come from their individual biology."  "In oncology, these practices and standards have been developed over decades. And in some situations, some of these cancer protocols haven't been updated in decades. There had been continual advancements in things like immunotherapy. What I'll say is that in oncology, they're always looking for the silver bullet. It's in the genome, it's in a biomarker, it's in immuno-oncology, it's in an organoid, it's in all of those types of things. So they have always tried to find that silver bullet. Fundamentally, what we do in First Ascent is that we believe that we have enough bullets, per se. We have enough drugs, per se. We're just not using them in the right ways. " #FirstAscentBiomedical #Cancer #Oncology firstascentbiomedical.com Download the transcript here

Jim Foote, Co-Founder and CEO of First Ascent Biomedical, is changing the standard of care for cancer treatment from 'try and hope' to 'test and treat'. The First Ascent platform combines functional drug testing of fresh biopsies, genomic sequencing, and an AI engine to assess a large panel of drugs and identify the most likely to be effective. Clinical data show a high correlation between how cancer cells respond in the lab test and how patients respond to the same drug, and is seen as a treatment guide for refractory cancer patients to identify novel drug combinations. Jim explains, "Fundamentally speaking, if we look at everybody on this planet from a DNA and RNA perspective, there are 8 billion people, and each one of us is different from the others due to our DNA and RNA. So if we acknowledge that biologically we're all different, then the problem that we're trying to solve is if we're all different, why are we treating each patient with the same standard of care? A process that has existed for a hundred years, and again, they've made substantial advancements, but functional precision medicine is really an opportunity to move away from a standard that's based on the laws of averages and really treat people based on an individual level, developed by results that come from their individual biology."  "In oncology, these practices and standards have been developed over decades. And in some situations, some of these cancer protocols haven't been updated in decades. There had been continual advancements in things like immunotherapy. What I'll say is that in oncology, they're always looking for the silver bullet. It's in the genome, it's in a biomarker, it's in immuno-oncology, it's in an organoid, it's in all of those types of things. So they have always tried to find that silver bullet. Fundamentally, what we do in First Ascent is that we believe that we have enough bullets, per se. We have enough drugs, per se. We're just not using them in the right ways. " #FirstAscentBiomedical #Cancer #Oncology firstascentbiomedical.com Listen to the podcast here

過去一年，你有沒有也覺得自己被各種 AI 相關內容鋪天蓋地地轟炸？從遇到疑難雜症請它幫忙搜尋、整理資料、處理公事，到純粹當成娛樂、請它生成各種有趣圖片，AI 的應用就像當年的網路搜尋一樣，幾乎無所不在地滲入我們的生活。 這集的三腳貓實驗室裡，在日常工作與生活中頻繁使用 AI 的「一般用戶」浩文和天豪，以及在生醫產業中運用 AI 參與藥物研究，並時刻關注AI前沿發展進程的「高階玩家」Mike，一起來聊聊現在 AI 在生醫學者日常中的各種使用場景，還有目前在大眾應用層面上的發展與限制。 我們或許已經習慣打開 AI 工具的網頁，在介面裡點選、輸入、獲得服務，就像多年前逐漸習慣使用 Google 一樣。但我們準備好迎接下一個階段了嗎？一個可以自己設計、客製化各種 Agent，自動幫你處理需求的時代？面對功能愈來愈強大的 AI 工具，你是否也開始擔心，身為「人」在科學研究中的角色，會不會很快被取代？歡迎你來聽聽這一集，和我們一起思考、一起面對這個正洶湧而來的新時代。 相關連結 如何使用AI工具提升科學研究生產力: Dr. Candice Chu's talk https://www.youtube.com/watch?v=CTTESpCK4yc https://www.nature.com/articles/d41586-024-03775-7 Chain of thought prompting: https://www.prompthub.us/blog/chain-of-thought-prompting-guide https://research.google/blog/accelerating-scientific-breakthroughs-with-an-ai-co-scientist/ 工作人員 內容製作：MIke、浩文、天豪 後製：天豪 文案：天豪 音樂：雯薇 封面：雯薇 上架：天豪 宣傳：Angel、雯薇 -- Hosting provided by SoundOn

"Europe does not want to be the client" of the US or China in the field of technology, French President Emmanuel Macron has told tech and political leaders at a "digital sovereignty summit" in Berlin. During the event, biotech company Owkin unveiled a new pan-European platform to make biological data "AI-ready". CEO Thomas Clozel speaks to FRANCE 24 about how new agentic and reasoning models can help take medical research to the next level. 

Send us a textWhy are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine?In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I've recorded about data equity and building ethical, community-centered AI.Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets. This underrepresentation isn't just a data gap—it's a clinical risk.We dive into disparities between healthcare systems, the promise of digital pathology as a low-cost entry point, the dangers of “parachute science,” and how Victor is building a living, ethical, transparent biobank through Omica. AI—built for true precision medicine rooted in community trust.Highlights with Timestamps[00:00–01:40] Personal cancer experiences and diagnostic uncertainty[01:40–06:50] Victor's medical journey across Mexico and the U.S.[06:50–11:42] The digitization gap: empathy vs. tech[11:42–16:43] The “coffee diversity” metaphor for genomic diversity[16:43–19:34] Funding disparities & the biotech cold-start problem[19:34–25:44] Digital pathology as a gateway to precision medicine[25:44–31:44] Avoiding “parachute science” and building community-first research[31:44–36:05] The Nagoya Protocol and benefit-sharing[36:05–41:47] Omica.Ai's work, goals, and clinical-embedded approach[41:47–49:36] Creating future-proof, embedded biobanks[49:36–53:35] Blockchain for transparency and patient trust[53:35–54:39] Victor's call to action: collaborate, include, and stay humanResources from This EpisodeOmica.Ai – Community-driven precision medicine platformNagoya Protocol – Framework for equitable biological useKey InsightsCancer is personal—even for experts

Doi Guinanao is Founder at AYO Biomedical Technologies.AYO Biomedical Technologies offers advanced wound care management solutions. The company is headquartered in Bacolod City, Philippines where most don't have access to high-quality biomedical services such as the Negative Pressure Wound Therapy (NPWT). AYO Biomedical Technologies offers advanced wound care solutions at unparalleled rates accessible to all, especially in third world countries. Its co-founders value social impact above all else and believe health is a universal right. While the company continues to develop disruptive advances in the advanced wound care management industry, it keeps in mind that any advances should not result in barriers to access among marginalized communities. This episode is recorded live at the Bacolod Accelerator Hub (ALPHA Hub) in Bacolod City.In this episode:00:47 Ano ang AYO Tech?03:23 What problem is being solved? 07:41 What solution is being provided? 21:33 What are stories behind the startup? 32:18 What is the vision? 41:27 How can listeners find more information?AYO BIOMEDICAL TECHNOLOGIESWebsite: https://ayobiomed.comFacebook: https://facebook.com/profile.php?id=100071273176777BACOLOD ACCELERATOR HUBFacebook: https://facebook.com/profile.php?id=61566996707356THIS EPISODE IS CO-PRODUCED BY:Yspaces: ⁠⁠https://knowyourspaceph.com⁠⁠Apeiron: ⁠⁠https://apeirongrp.com⁠⁠Twala: ⁠⁠https://twala.io⁠⁠Symph: ⁠⁠https://symph.co⁠⁠Secuna: ⁠⁠https://secuna.io⁠⁠MaroonStudios: ⁠⁠https://maroonstudios.com⁠⁠AIMHI: ⁠⁠https://aimhi.ai⁠⁠CompareLoans: ⁠⁠http://compareloans.ph⁠⁠CHECK OUT OUR PARTNERS:Ask Lex PH Academy: ⁠⁠https://asklexph.com⁠⁠ (5% discount on e-learning courses! Code: ALPHAXSUP)Argum AI: ⁠⁠http://argum.ai⁠⁠PIXEL by Eplayment: ⁠⁠https://pixel.eplayment.co/auth/sign-up?r=PIXELXSUP1⁠⁠ (Sign up using Code: PIXELXSUP1)School of Profits: ⁠⁠https://schoolofprofits.academy⁠⁠Founders Launchpad: ⁠⁠https://founderslaunchpad.vc⁠⁠Hier Business Solutions: ⁠⁠https://hierpayroll.com⁠⁠Agile Data Solutions (Hustle PH): ⁠⁠https://agiledatasolutions.tech⁠⁠Smile Checks: ⁠⁠https://getsmilechecks.com⁠⁠CloudCFO: ⁠⁠https://cloudcfo.ph⁠⁠ (Free financial assessment, process onboarding, and 6-month QuickBooks subscription! Mention: Start Up Podcast PH)Cloverly: ⁠⁠https://cloverly.tech⁠⁠BuddyBetes: ⁠⁠https://buddybetes.com⁠⁠HKB Digital Services: ⁠⁠https://contakt-ph.com⁠⁠ (10% discount on RFID Business Cards! Code: CONTAKTXSUP)Hyperstacks: https://hyperstacksinc.comOneCFO: ⁠⁠https://onecfoph.co⁠⁠ (10% discount on CFO services! Code: ONECFOXSUP)UNAWA: ⁠⁠https://unawa.asia⁠⁠Wunderbrand: ⁠⁠https://wunderbrand.com⁠⁠DVCode Technologies Inc: ⁠⁠https://dvcode.tech⁠⁠NutriCoach: ⁠⁠https://nutricoach.com⁠⁠Uplift Code Camp: ⁠⁠https://upliftcodecamp.com⁠⁠ (5% discount on bootcamps and courses! Code: UPLIFTSTARTUPPH)START UP PODCAST PHYouTube: ⁠⁠https://youtube.com/startuppodcastph⁠⁠Spotify: ⁠⁠https://open.spotify.com/show/6BObuPvMfoZzdlJeb1XXVa⁠⁠Apple Podcasts: ⁠⁠https://podcasts.apple.com/us/podcast/start-up-podcast/id1576462394⁠⁠Facebook: ⁠⁠https://facebook.com/startuppodcastph⁠⁠Patreon: ⁠⁠https://patreon.com/StartUpPodcastPH⁠⁠PIXEL: ⁠⁠https://pixel.eplayment.co/dl/startuppodcastph⁠⁠Website: ⁠⁠https://phstartup.online⁠⁠This episode is edited by the team at: ⁠⁠https://tasharivera.com⁠

In this episode of MyHeart.net, cardiologist Dr. Alan Bouchard sits down with Dr. Timothy Garvey, Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham, to discuss the evolving definition of obesity as a disease. Drawing from The Lancet's 2025 clinical framework, Dr. Garvey explains when excess adiposity begins to impair organ function, how this redefinition changes patient care, and why understanding obesity as a chronic disease is essential for preventing cardiometabolic complications.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

From Biomedical to Bedside: How Academic Health Systems Are Leading the AI Revolution in Patient Care Join us for an in-depth conversation with Dr. Ryan Sadeghian, System CMIO at University of Toledo Health, as he shares his unique journey from healthcare consultant to practicing pediatrician to AI implementation leader. In this episode, we explore how academic health systems are uniquely positioned to drive healthcare AI innovation, balancing the dual mission of education and patient care while building practical AI solutions that solve real workflow challenges. Dr. Sadeghian discusses his organization's approach to developing internal AI capabilities, managing vendor relationships, and creating sustainable change management strategies that ensure successful AI adoption across clinical and administrative teams. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Drawing on his background in science and international affairs, UP alum Scott Knackstedt shares how innovation can be used to advance health equity in low-resource settings around the world, transforming barriers to access into opportunities for impact. As a Senior Commercialization Officer at PATH, a global health nonprofit based in Seattle, Scott helps develop affordable, life-saving technologies that range from low-cost devices to next-generation vaccine platforms. His work focuses on overcoming access challenges through formulation and delivery innovations that make health solutions more effective, scalable, and equitable.

In this powerful episode, we are honored to welcome Brigadier General Roger S. Giraud, the 21st Chief of the U.S. Army Medical Service Corps (MSC), Commanding General of Medical Readiness Command–Europe, Command Surgeon for U.S. Army Europe and Africa, and Director of the Defense Health Network Europe. With a career spanning over three decades, BG Giraud brings unmatched leadership experience across tactical, operational, and strategic levels. In this episode, he shares the vision and strategy to achieve the future of the Medical Service Corps and breaks down what it takes to build, grow, and lead a world-class team of Medical Service Corps Officers and Warrant Officers.Episode Highlights:People Are the Priority: BG Giraud outlines our three strategic priorities for the Medical Service Corps. Recruit phenomenal talent, Develop it deliberately, and Retain the best to meet Army modernization demands.Talent Management: Why it's essential for officers to master their craft, advocate for their careers, and understand the flexibility of the MSC structure.The Future of Army Medicine: A candid discussion on leveraging data, artificial intelligence, and structure changes to make the MSC more adaptable and impactful.Mentorship & Leadership: Reflections from a career that spans Kosovo, Iraq, Afghanistan, Korea, Germany, the Pentagon, and beyond. BG Giraud shares the leadership principles that shaped him and how MSC officers at all levels can apply them.Practical Advice for Officers: Whether you're just commissioning or preparing for strategic-level command, BG Giraud offers honest guidance for career growth, resilience, and staying mission ready.Call to Action: BG Giraud emphasizes staying relevant, investing in professional development, and keeping MSC officers at the forefront of the Medical Service Corps mission “conserve the fighting strength now and into the future so others may live.”About BG Roger S. Giraud. BG Giraud is a Distinguished Military Graduate of Texas A&M, with dual bachelor's degrees in Biomedical and Animal Science. He earned his Master of Health Administration from Baylor University and a Master of Strategic Studies from the U.S. Army War College. His command and staff roles include battalion, brigade, and division-level leadership; deployments to Iraq, Kosovo, and Afghanistan; and multiple executive roles at OTSG and MEDCOM HQ. His awards include the Legion of Merit, Bronze Star, Expert Field Medical Badge, German Armed Forces Proficiency Badge (Gold), and membership in the Order of Military Medical Merit. He is also the recipient of The Surgeon General's prestigious “A” Proficiency Designator.Pro Tip: Watch alongside the MSC Strategy Map on our YouTube channel to follow BG Giraud's discussion in action.Book reference: The History of the U.S. Army Medical Service Corps by Richard V.N. Ginn, https://www.amazon.com/History-Medical-Service-Richard-2015-10-19/dp/B01K3JNXHEDisclaimer: The views expressed in this podcast are the guests and host's alone and do not reflect the official position of the Medical Service Corps, the Department of Defense, or the US Government. All information discussed is unclassified approved for public release and found on open cleared sources.For more episodes listen on Apple Podcasts, Spotify, or YouTube @ Be All You Can Be MSC For more information, suggestions, or questions please contact: beallyoucanbemsc@gmail.com

Can kids with autism get better? Can they heal? In this episode we talk with Greer McGuinness, founder of Biomedical Healing for Kids, to explore her inspiring journey as a mother of an autistic child who was on a mission to find healing for him, and what she discovered and the dramatic transformation she witnessed expanded her mission to helping other children with autism and ADHD heal, too. She earned a master's degree in health science, equipping herself with the knowledge to better understand the intricate connections between health and the body's overall function, and combined with her 15 years in the medical field, she developed expertise in functional and integrative medicine—an approach that focuses on identifying and addressing the underlying causes of health challenges rather than merely masking symptoms.Using alternative and holistic therapies in her personalized consulting services, she designs evidence-based, functional, and integrative health strategies tailored to meet the unique individual needs of each child with an autism diagnosis.

Atrial fibrillation raises stroke risk fivefold. But what if blood thinners are too dangerous after a brain bleed or major fall?A new monthly injection, abelacimab, may prevent strokes without the bleeding risk of traditional anticoagulants.Is this the future for AFib patients who can't take blood thinners? Cardiologist Dr. Alain Bouchard discusses this groundbreaking drug with Dr. Charles V. Pollack, a consultant clinical scientist and professional educator with Novartis, owner of abelacimab.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

Are busy lifestyles and convenience foods quietly reshaping our health? Cardiologist Dr. Alain Bouchard talks with dietitian and researcher Dr. Amy Goss about the impact of ultra-processed foods on children, families, and communities. From school lunches to quick weeknight dinners, they share tips for identifying hidden risks on food labels and creating healthier meals...even on a budget.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

In this episode of Medsider Radio, we sat down with Marc Penna, CEO of Voyager Biomedical. Voyager is a clinical-stage company tackling one of the most persistent challenges in dialysis care: reliable vascular access. Marc has more than 20 years of experience leading clinical research and regulatory programs across cardiology, vascular disease, and oncology. Since 2014, he has focused on early-stage ventures, with leadership roles at Intact Vascular and Vesper Medical — both acquired by Philips — as well as senior positions at Edwards Lifesciences, Boston Scientific, and AngioDynamics.In this interview, Marc shares how to pressure-test new medtech ideas, why collaboration with regulators and trial sites builds lasting credibility, and how disciplined fundraising and smart exit planning can set startups apart.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Marc Penna.

Dr. Jonathan Morris is the Executive Medical Director of Immersive and Experiential Learning at the Mayo Clinic. He is also the Medical Director of Biomedical and Scientific Visualization and helped set up their Anatomic Modeling Unit nearly 19 years ago. With over 23 years at the Mayo Clinic, much of it working with 3D printing, Dr. Morris has a lot of experience with the technology. He's not always a happy 3D printing user, but here he passionately explains what it can do for patients and doctors. We also talk about how 3D printed models gained a foothold at Mayo, how they grew in use, and how they're used today. We talk about Mayo Clinic's pursuit of 3D printing implants in the hospital and other pioneering work in a must-listen episode for anyone in the medical field. This episode of the 3DPOD is brought to you by Würth Additive Group, industry leaders in digital inventory and physical supply chain solutions. From factory floors to frontline operations, Würth Additive helps manufacturers streamline sourcing and stay production-ready with 3D printing, on-demand parts, and smart inventory strategies.

Our hosts, Ali and Paul, speak with Dr. Udunna Anazodo and Dr. Marouf Adewole about their groundbreaking work on the BRATS Africa challenge and building AI-ready brain tumor imaging datasets across Nigeria. They share insights into the challenges of medical imaging in resource-limited settings, the power of global collaboration, and how their efforts are shaping the future of inclusive AI in radiology.

Welcome to Episode 271 of Autism Parenting Secrets.Parents are often told that autism is fixed, with limited options beyond therapies to manage behaviors. That definition is wrong. Autism is biomedical—and that opens up entirely new possibilities for parents.My guest this week is Dr. Christian Bogner, a physician, educator, and father whose son continues to make meaningful improvements. His personal and professional journey has led him to work with over 1,000 families worldwide, uncovering the genetic, biochemical, and environmental factors driving autism and chronic disease.In this conversation, Dr. Bogner shares why autism must be understood as biomedical, why families can't afford to wait for mainstream medicine to catch up, and what simple, affordable steps parents can take today to help their children thrive.The secret this week is… Autism Is BIOMEDICALYou'll Discover:Why the Current Definition of Autism Misses the Mark (2:32)How Parents Can Prepare the Body Before Targeting the Gut (11:15)Why Simple Stool Testing Provides a Powerful Starting Point (14:10)The Power of a Gut Balancing Protocol (28:05)How Environmental Toxins Like Glyphosate Disrupt Gut Health (34:36)The Connection Between Gut-Derived Chemicals and Altered Consciousness (52:11)About Our Guest:Christian Bogner, MD, FACOG, CFMNPDr. Christian Bogner's journey into functional and integrative medicine began in 2007 when his eldest son was diagnosed with autism at just 2.5 years old. Since then, he has spoken at conferences worldwide, consulted with over 1,000 families, and dedicated his career to uncovering the genetic, biochemical, and environmental factors driving autism and other chronic conditions.Board-certified in obstetrics and gynecology with additional certification in functional medicine, Dr. Bogner is passionate about the microbiome, plant-based nutrition, and innovative therapies that improve accessibility for families. He has helped develop software to translate stool data into personalized guidance, advanced cold laser technology for affordable photobiomodulation, and targeted nutraceuticals to support detoxification and inflammation resolution.In 2024, he co-founded Autism Is Biomedical, Inc., a nonprofit committed to providing families with resources, counseling, and access to biomedical interventions. Working closely with visionary medical physicist Alex Zaharakis, Dr. Bogner continues to push the boundaries of science and care, helping families find hope, healing, and a clearer path forward.References In This Episode:Learn more about Dr. Bogner's work: Bogner HealthVisit the nonprofit: Autism Is BiomedicalSPELLERS DocumentaryDMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences by Rick StrassmanResearched ElementsThioguard LotionAdditional Resources:To learn more about personalized 1:1 support, go to www.elevatehowyounavigate.comTake The Quiz: What's YOUR Top Autism Parenting Blindspot?If you enjoyed this episode, share it with your friends.

Dr. Vera Bittner, Section Head of General Cardiology, Prevention, and Imaging and Medical Director of the Coronary Care Unit at UAB, discusses the risks associated with elevated triglycerides and how to combat this potentially dangerous condition.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

The Katrina 20 Local Planning Committee is commemorating Hurricane Katrina with performances, art and more, throughout the city, stretching to Mississippi and Alabama.The Coastal Desk's Eva Tesfaye spoke with Asali deVan Ecclesiastes, executive director of the Ashé Cultural Arts Center, to learn more about the events and how you can get involved. For months, the Trump administration has been cutting funding for university-based scientific research across the nation. But the Louisiana Biomedical Research Network recently logged a ‘win'with the renewal of one of its grants from the National Institute of Health–$20 million spread out over five years.Dr. Konstantin "Gus" Kousoulas, a professor and department head in the LSU School Veterinary Medicine's Department of Pathobiological Sciences and director of their Division of Biotechnology and Molecular Medicine, joined us to discuss the grant and how it will be used.—Today's episode of Louisiana Considered was hosted by Adam Vos. Our managing producer is Alana Schreiber. We get production support from Garrett Pittman and our assistant producer Aubry Procell.You can listen to Louisiana Considered Monday through Friday at noon and 7 p.m. It's available on Spotify, the NPR App and wherever you get your podcasts. Louisiana Considered wants to hear from you!Please fill out our pitch line to let us know what kinds of story ideas you have for our show. And while you're at it, fill out our listener survey! We want to keep bringing you the kinds of conversations you'd like to listen to.Louisiana Considered is made possible with support from our listeners. Thank you!

Medical educators generally acknowledge the importance of training doctors who care for the whole patient rather than just treat the disease. Most medical school curricula attempt to teach to that philosophy, but how successful are they, really?    Our guest, Robert C. Smith, is a physician and author, who trained with Dr. George Engel, founder of the biopsychosocial model. In his new book, Dr. Smith argues that medical education mostly pays “lip service” when it comes to training physicians who are ready and comfortable serving patients who struggle with unaddressed psychosocial and psychological needs.    He calls for a complete overhaul of medical education. What would that take? Is an overhaul feasible, or are the market forces that now drive medicine as big business too overpowering to allow for transformative change?   

In this episode, Duane Mancini welcomes to the show Dasha Tyshlek, Founder & Chief Strategic Officer of StratCraft. An innovator who's bridging the gap between groundbreaking research and market-ready technologies, Dasha shares her fascinating journey from a science-loving student to a leader in the medtech, biotech, and defense industries. Learn how her experiences at Bridgewater Associates and Micro-Ant have shaped her approach to strategic planning and commercialization, discover the mission behind her consulting firm, StratCraft, and the impact of her Biomedical Frontiers podcast. Plus, get an inside look at the upcoming Disrupt Health conference in Jacksonville, where real-world case studies and innovative discussions promise to elevate the industry.Dasha Tyshlek LinkedInStratCraft WebsiteDisrupt Health Event WebsiteBiomedical Frontiers Podcast“Principles: Life & Work” by Ray DalioDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedIn

Why are women constantly misdiagnosed and dismissed when they bring up perimenopausal symptoms to their doctors? The answer might shock you—and it's costing women their quality of life and long-term health.In this episode of Broads, I talk with Dr. Amy Killen about the massive education gap in women's hormone health, why the medical establishment got scared of HRT in 2002, and what the latest research actually shows about hormone replacement therapy. We dive deep into the difference between bioidentical and synthetic hormones, the supplements that actually matter for aging women, and why every woman deserves a conversation about hormone optimization.Dr. Amy Killen is a board-certified emergency physician who transitioned into hormone optimization and regenerative medicine after experiencing her own health challenges. She's the founder of HopBox supplements, co-founder of Reputable Health, and is dedicated to educating women about hormone health that most doctors never learned in medical school.We Also Discuss:05:27 – What are the biggest misconceptions when it comes to women's health? 07:03 – Why women are constantly misdiagnosed or dismissed by doctors 08:37 – The 2002 Women's Health Initiative study that changed everything 12:09 – Are doctors getting perimenopause/menopause education now? 14:36 – Why "that's just part of getting older" is a harmful narrative 15:41 – How to find doctors with hormone knowledge 17:27 – What is HRT and hormone replacement therapy? 18:18 – Why women might want to consider hormone replacement 19:42 – How hormones are preventative for chronic diseases 21:08 – How to know if symptoms are perimenopause vs other issues 23:06 – What tests to ask for and where to get them 24:44 – Addressing fears about HRT and breast cancer 28:06 – When is the right time to start HRT? 29:14 – Do you have to take hormones forever? 40:31 – Finding your perfect hormone "cocktail" 45:00 – Supplements: what women actually need as they age 54:58 – Why women should take creatine 57:40 – How to figure out if a supplement is actually workingThank You to Our Sponsors:Broads: Broads 1:1 – Ready to ditch the bullshit and start feeling good in your body? Choose your level and let's do this together. Apply for BroadsCOACH or BroadsCHAMPION today at broads.appLegion: Use code Tara20 for 20% off your first order and double loyalty cash back any order after that when you shop at LegionAthletics.comMomentous: Head to livemomentous.com and use code TARA for up to 35% off your first order. Because foundational health isn't optional – it's everything.Find more from Tara: Website: https://www.taralaferrara.com/Instagram: @taralaferrara @broads.podcast @broads.appYoutube: Tara LaFerraraTiktok: @taralaferraraFind more from Dr. Amy Killen: Website: https://hopbox.life/Instagram: @dr.amybkillen

In this episode of A Shot in the Arm podcast, host Ben Plumley discusses the Kigali International AIDS Society Conference with guests Solange Baptiste from ITPC and Rosemary Mburu from WACI Health. They explore the importance of community voices in global health innovations, the challenges of funding cuts, and the significance of long-acting antiretroviral therapies. Additionally, they touch upon the roles of UNAIDS and the Global Fund, advanced HIV disease, and the critical need for prioritizing global health and HIV funding. 00:00 Introduction to the Podcast 00:16 Kigali International AIDS Society Conference Overview 00:40 Community Involvement and Clinical Trials 00:51 Introducing the Guests: Solange Baptiste and Rosemary Mburu 02:13 Discussion on the Kigali AIDS Conference 04:48 Challenges and Strategies in Global Health Funding 11:32 Community Leadership and Global Health Architecture 14:54 UNAIDS and Global Fund Presence at the Conference 26:00 Scientific Innovations and Long-Acting Treatments 31:59 Integration and Efficiency in Global Health 35:15 Conclusion and Final Thoughts

In this episode of the Radiology Artificial Intelligence Podcast, host Dr. Paul Yi speaks with Drs. Eric and Kevin Wu, recent Stanford PhDs, about their journey through academia, industry, and the startup world. They dive into their latest project, MedArena, a physician-powered platform designed to evaluate medical LLMs, and explore how AI can be more effectively integrated into real-world clinical workflows.

00:33 Was a boom in papers driven by AI?A spike in papers formulaically analysing a public data set has sparked worries that AI is being used to generate low quality and potentially misleading analyses.Nature: AI linked to explosion of low-quality biomedical research papers08:07 Lenses that give humans infrared visionResearchers in China have created contact lenses that can allow humans to see infrared light, which could help with search and rescue missions, sending secret messages and even surgery.Nature: These contact lenses give people infrared vision — even with their eyes shut14:17 Does the Earth's core have a leak?Geologists have uncovered the strongest evidence yet that Earth's core is leaking. Rocks from Hawaii were found to contain isotopes of a rare element, which suggests the material originally came from the core. More work will need to be done to rule out other explanations.Nature: Is Earth's core leaking? Volcanic rocks provide strongest evidence yetSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday. Hosted on Acast. See acast.com/privacy for more information.